HWAM
Hennion & Walsh Asset Management Portfolio holdings
AUM
$2.48B
1-Year Return
14.59%
This Quarter Return
-3.18%
1 Year Return
+14.59%
3 Year Return
+61.58%
5 Year Return
–
10 Year Return
–
AUM
$1.57B
AUM Growth
-$118M
(-7%)
Cap. Flow
-$42M
Cap. Flow
% of AUM
-2.68%
Top 10 Holdings %
Top 10 Hldgs %
17.86%
Holding
854
New
57
Increased
321
Reduced
406
Closed
55
Top Buys
Top Sells
| 1 |
Schwab US Dividend Equity ETF
SCHD
|
+$19.7M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$4.42M |
| 3 |
BlackRock MuniHoldings Fund
MHD
|
+$3.7M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$3.08M |
| 5 |
EIM
Eaton Vance Municipal Bond Fund
EIM
|
+$3.03M |
Sector Composition
| 1 | Healthcare | 12.25% |
| 2 | Financials | 9.89% |
| 3 | Technology | 8.65% |
| 4 | Industrials | 4.95% |
| 5 | Consumer Discretionary | 4.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
426
Bed Bath & Beyond, Inc.
BBBY
$638M
| $745K | 0.05% |
47,112
-7,321
| -13% | -$116K |
|
427
Union Pacific
UNP
$128B
| $745K | 0.05% |
3,659
+335
| +10% | +$68.2K |
|
|
HYB
428
DELISTED
New America High Income Fund, Inc.
HYB
| $743K | 0.05% |
114,670
-51,720
| -31% | -$335K |
|
429
KLA
KLAC
$121B
| $739K | 0.05% |
1,612
+352
| +28% | +$161K |
|
430
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4B
| $737K | 0.05% |
39,318
+24,909
| +173% | +$467K |
|
431
ServiceNow
NOW
$195B
| $734K | 0.05% |
1,314
-1,719
| -57% | -$961K |
|
|
PHT
432
Pioneer High Income Fund
PHT
$245M
| $734K | 0.05% |
109,333
-37
| -0% | -$248 |
|
433
Netflix
NFLX
$537B
| $715K | 0.05% |
1,894
+34
| +2% | +$12.8K |
|
434
SEI Investments
SEIC
$10.7B
| $715K | 0.05% |
11,866
+275
| +2% | +$16.6K |
|
435
Ultragenyx Pharmaceutical
RARE
$3.04B
| $704K | 0.04% |
19,751
+1,426
| +8% | +$50.8K |
|
436
Jacobs Solutions
J
$17.3B
| $703K | 0.04% |
6,226
-8,492
| -58% | -$959K |
|
437
Ethan Allen Interiors
ETD
$760M
| $702K | 0.04% |
23,488
-1,673
| -7% | -$50K |
|
438
Marathon Petroleum
MPC
$55.1B
| $699K | 0.04% |
+4,618
| New | +$699K |
|
439
Sturm, Ruger & Co
RGR
$576M
| $697K | 0.04% |
13,370
-743
| -5% | -$38.7K |
|
440
CRISPR Therapeutics
CRSP
$4.88B
| $695K | 0.04% |
15,315
+7,235
| +90% | +$328K |
|
441
B. Riley Financial
RILY
$162M
| $694K | 0.04% |
16,922
+2,592
| +18% | +$106K |
|
|
PYN
442
DELISTED
PIMCO New York Municipal Income Fund III
PYN
| $692K | 0.04% |
130,323
-3,407
| -3% | -$18.1K |
|
443
General Dynamics
GD
$86.8B
| $682K | 0.04% |
3,087
-1,192
| -28% | -$263K |
|
444
Telus
TU
$25B
| $679K | 0.04% |
41,573
-19,803
| -32% | -$324K |
|
445
Neurocrine Biosciences
NBIX
$14.3B
| $679K | 0.04% |
6,035
+435
| +8% | +$48.9K |
|
446
Travere Therapeutics
TVTX
$1.93B
| $678K | 0.04% |
75,873
-5,230
| -6% | -$46.8K |
|
447
RAPT Therapeutics
RAPT
$220M
| $674K | 0.04% |
5,071
+2,395
| +89% | +$318K |
|
448
Coca-Cola Femsa
KOF
$17.8B
| $670K | 0.04% |
8,539
+31
| +0.4% | +$2.43K |
|
449
Ardelyx
ARDX
$1.58B
| $664K | 0.04% |
162,639
+76,815
| +90% | +$313K |
|
450
Evergy
EVRG
$16.3B
| $664K | 0.04% |
13,087
+2,874
| +28% | +$146K |
|